The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diagnostic Testing of STDs-Global Market Insights and Sales Trends 2024
Synopsis
Sexually Transmitted Diseases (STDs) spread primarily through person-to-person sexual contacts. Varied testing technologies used for the identification and analysis of the STD contracted comprise the definition of ‘diagnostic testing of STDs’.
The global Diagnostic Testing of STDs market size is expected to reach US$ 130390 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Diagnostic Testing of STDs in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Diagnostic Testing of STDs market. Chlamydia testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gonorrhea testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diagnostic Testing of STDs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diagnostic Testing of STDs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diagnostic Testing of STDs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diagnostic Testing of STDs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diagnostic Testing of STDs covered in this report include Roche, Abbott, Becton Dickinson, BioMerieux, Danaher and Hologic, etc.
The global Diagnostic Testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
Becton Dickinson
BioMerieux
Danaher
Hologic
Global Diagnostic Testing of STDs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diagnostic Testing of STDs market, Segment by Type:
Chlamydia testing
Gonorrhea testing
P&S Syphilis testing
HPV testing
HSV testing
HIV testing
Chancroid testing
Global Diagnostic Testing of STDs market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Diagnostic Testing of STDs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Diagnostic Testing of STDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Sexually Transmitted Diseases (STDs) spread primarily through person-to-person sexual contacts. Varied testing technologies used for the identification and analysis of the STD contracted comprise the definition of ‘diagnostic testing of STDs’.
The global Diagnostic Testing of STDs market size is expected to reach US$ 130390 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Diagnostic Testing of STDs in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Diagnostic Testing of STDs market. Chlamydia testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gonorrhea testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diagnostic Testing of STDs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diagnostic Testing of STDs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diagnostic Testing of STDs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diagnostic Testing of STDs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diagnostic Testing of STDs covered in this report include Roche, Abbott, Becton Dickinson, BioMerieux, Danaher and Hologic, etc.
The global Diagnostic Testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
Becton Dickinson
BioMerieux
Danaher
Hologic
Global Diagnostic Testing of STDs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diagnostic Testing of STDs market, Segment by Type:
Chlamydia testing
Gonorrhea testing
P&S Syphilis testing
HPV testing
HSV testing
HIV testing
Chancroid testing
Global Diagnostic Testing of STDs market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Diagnostic Testing of STDs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Diagnostic Testing of STDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Diagnostic Testing of STDs Market Overview
1.1 Diagnostic Testing of STDs Product Overview
1.2 Diagnostic Testing of STDs Market Segment by Type
1.2.1 Chlamydia testing
1.2.2 Gonorrhea testing
1.2.3 P&S Syphilis testing
1.2.4 HPV testing
1.2.5 HSV testing
1.2.6 HIV testing
1.2.7 Chancroid testing
1.3 Global Diagnostic Testing of STDs Market Size by Type
1.3.1 Global Diagnostic Testing of STDs Market Size Overview by Type (2018-2029)
1.3.2 Global Diagnostic Testing of STDs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Diagnostic Testing of STDs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Diagnostic Testing of STDs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Diagnostic Testing of STDs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Diagnostic Testing of STDs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Diagnostic Testing of STDs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Diagnostic Testing of STDs Sales Breakdown by Type (2018-2023)
2 Global Diagnostic Testing of STDs Market Competition by Company
2.1 Global Top Players by Diagnostic Testing of STDs Sales (2018-2023)
2.2 Global Top Players by Diagnostic Testing of STDs Revenue (2018-2023)
2.3 Global Top Players by Diagnostic Testing of STDs Price (2018-2023)
2.4 Global Top Manufacturers Diagnostic Testing of STDs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Diagnostic Testing of STDs Market Competitive Situation and Trends
2.5.1 Diagnostic Testing of STDs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Diagnostic Testing of STDs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diagnostic Testing of STDs as of 2022)
2.7 Date of Key Manufacturers Enter into Diagnostic Testing of STDs Market
2.8 Key Manufacturers Diagnostic Testing of STDs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Diagnostic Testing of STDs Status and Outlook by Region
3.1 Global Diagnostic Testing of STDs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Diagnostic Testing of STDs Historic Market Size by Region
3.2.1 Global Diagnostic Testing of STDs Sales in Volume by Region (2018-2023)
3.2.2 Global Diagnostic Testing of STDs Sales in Value by Region (2018-2023)
3.2.3 Global Diagnostic Testing of STDs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Diagnostic Testing of STDs Forecasted Market Size by Region
3.3.1 Global Diagnostic Testing of STDs Sales in Volume by Region (2024-2029)
3.3.2 Global Diagnostic Testing of STDs Sales in Value by Region (2024-2029)
3.3.3 Global Diagnostic Testing of STDs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Diagnostic Testing of STDs by Application
4.1 Diagnostic Testing of STDs Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Diagnostic Testing of STDs Market Size by Application
4.2.1 Global Diagnostic Testing of STDs Market Size Overview by Application (2018-2029)
4.2.2 Global Diagnostic Testing of STDs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Diagnostic Testing of STDs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Diagnostic Testing of STDs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Diagnostic Testing of STDs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Diagnostic Testing of STDs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Diagnostic Testing of STDs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Diagnostic Testing of STDs Sales Breakdown by Application (2018-2023)
5 North America Diagnostic Testing of STDs by Country
5.1 North America Diagnostic Testing of STDs Historic Market Size by Country
5.1.1 North America Diagnostic Testing of STDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Diagnostic Testing of STDs Sales in Volume by Country (2018-2023)
5.1.3 North America Diagnostic Testing of STDs Sales in Value by Country (2018-2023)
5.2 North America Diagnostic Testing of STDs Forecasted Market Size by Country
5.2.1 North America Diagnostic Testing of STDs Sales in Volume by Country (2024-2029)
5.2.2 North America Diagnostic Testing of STDs Sales in Value by Country (2024-2029)
6 Europe Diagnostic Testing of STDs by Country
6.1 Europe Diagnostic Testing of STDs Historic Market Size by Country
6.1.1 Europe Diagnostic Testing of STDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Diagnostic Testing of STDs Sales in Volume by Country (2018-2023)
6.1.3 Europe Diagnostic Testing of STDs Sales in Value by Country (2018-2023)
6.2 Europe Diagnostic Testing of STDs Forecasted Market Size by Country
6.2.1 Europe Diagnostic Testing of STDs Sales in Volume by Country (2024-2029)
6.2.2 Europe Diagnostic Testing of STDs Sales in Value by Country (2024-2029)
7 Asia-Pacific Diagnostic Testing of STDs by Region
7.1 Asia-Pacific Diagnostic Testing of STDs Historic Market Size by Region
7.1.1 Asia-Pacific Diagnostic Testing of STDs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Diagnostic Testing of STDs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Diagnostic Testing of STDs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Diagnostic Testing of STDs Forecasted Market Size by Region
7.2.1 Asia-Pacific Diagnostic Testing of STDs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Diagnostic Testing of STDs Sales in Value by Region (2024-2029)
8 Latin America Diagnostic Testing of STDs by Country
8.1 Latin America Diagnostic Testing of STDs Historic Market Size by Country
8.1.1 Latin America Diagnostic Testing of STDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Diagnostic Testing of STDs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Diagnostic Testing of STDs Sales in Value by Country (2018-2023)
8.2 Latin America Diagnostic Testing of STDs Forecasted Market Size by Country
8.2.1 Latin America Diagnostic Testing of STDs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Diagnostic Testing of STDs Sales in Value by Country (2024-2029)
9 Middle East and Africa Diagnostic Testing of STDs by Country
9.1 Middle East and Africa Diagnostic Testing of STDs Historic Market Size by Country
9.1.1 Middle East and Africa Diagnostic Testing of STDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Diagnostic Testing of STDs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Diagnostic Testing of STDs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Diagnostic Testing of STDs Forecasted Market Size by Country
9.2.1 Middle East and Africa Diagnostic Testing of STDs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Diagnostic Testing of STDs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Roche Diagnostic Testing of STDs Products Offered
10.1.5 Roche Recent Development
10.2 Abbott
10.2.1 Abbott Company Information
10.2.2 Abbott Introduction and Business Overview
10.2.3 Abbott Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Diagnostic Testing of STDs Products Offered
10.2.5 Abbott Recent Development
10.3 Becton Dickinson
10.3.1 Becton Dickinson Company Information
10.3.2 Becton Dickinson Introduction and Business Overview
10.3.3 Becton Dickinson Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Becton Dickinson Diagnostic Testing of STDs Products Offered
10.3.5 Becton Dickinson Recent Development
10.4 BioMerieux
10.4.1 BioMerieux Company Information
10.4.2 BioMerieux Introduction and Business Overview
10.4.3 BioMerieux Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BioMerieux Diagnostic Testing of STDs Products Offered
10.4.5 BioMerieux Recent Development
10.5 Danaher
10.5.1 Danaher Company Information
10.5.2 Danaher Introduction and Business Overview
10.5.3 Danaher Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Danaher Diagnostic Testing of STDs Products Offered
10.5.5 Danaher Recent Development
10.6 Hologic
10.6.1 Hologic Company Information
10.6.2 Hologic Introduction and Business Overview
10.6.3 Hologic Diagnostic Testing of STDs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Hologic Diagnostic Testing of STDs Products Offered
10.6.5 Hologic Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Diagnostic Testing of STDs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Diagnostic Testing of STDs Industrial Chain Analysis
11.4 Diagnostic Testing of STDs Market Dynamics
11.4.1 Diagnostic Testing of STDs Industry Trends
11.4.2 Diagnostic Testing of STDs Market Drivers
11.4.3 Diagnostic Testing of STDs Market Challenges
11.4.4 Diagnostic Testing of STDs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Diagnostic Testing of STDs Distributors
12.3 Diagnostic Testing of STDs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
